ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,171Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 6645

$2.28M Total Retail Price of All Prescriptions

Rank: 63 out of 6645

452 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 26,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

60 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,381 1,344 1 2
SIMVASTATIN 889 868 2 1
CREON 732 732 3 114
NEXIUM 729 727 4 40
ALENDRONATE SODIUM 726 711 5 14
DIOVAN 674 664 6 19
LOSARTAN POTASSIUM 597 582 7 12
LIDODERM 533 531 8 53
JANUVIA 507 507 9 38
ATORVASTATIN CALCIUM 503 497 10 10
ZOLPIDEM TARTRATE 497 497 11 17
IBANDRONATE SODIUM 496 494 10 12 147
METOPROLOL TARTRATE 491 490 13 13
GABAPENTIN 464 464 14 18
METOPROLOL SUCCINATE 453 445 15 24
LEVOTHYROXINE SODIUM 440 438 16 4
CLOPIDOGREL 427 427 17 36
DONEPEZIL HCL 398 398 18 27
NAMENDA 392 379 19 41
CRESTOR 382 381 20 34
CARVEDILOL 368 368 21 25
TRIAMCINOLONE ACETONIDE 354 353 22 55
DEXILANT 322 321 23 102
RANITIDINE HCL 315 315 24 51
METFORMIN HCL 314 295 25 7
GLIPIZIDE 313 310 26 23
TAMSULOSIN HCL 313 303 26 22
FUROSEMIDE 311 310 28 11
TRICOR 307 307 29 138
FAMOTIDINE 297 297 30 33
BENICAR 282 281 31 84
OMEPRAZOLE 277 276 32 6
ZENPEP 276 276 33 210
SINGULAIR 275 275 34 76
BENAZEPRIL HCL 261 244 35 21
PLAVIX 260 260 36 49
LOVAZA 252 249 37 68
NIFEDIPINE ER 229 229 38 82
VOLTAREN 228 228 39 108
ATENOLOL 216 216 40 8
ISOSORBIDE MONONITRATE ER 205 205 41 66
MONTELUKAST SODIUM 193 193 42 128
AZITHROMYCIN 177 168 43 44
CELEBREX 173 173 44 54
NAPHAZOLINE HCL 173 173 44 215
SPIRIVA 163 163 46 65
ONGLYZA 153 153 47 168
ZETIA 151 151 48 87
JANUMET 149 149 49 132
BONIVA 145 145 50 191
DOXAZOSIN MESYLATE 141 141 51 81
ECONAZOLE NITRATE 138 138 52 263
MIRTAZAPINE 136 136 53 70
LOSARTAN-HYDROCHLOROTHIAZIDE 133 129 54 62
LYRICA 131 129 55 127
PAROXETINE HCL 129 129 56 72
METOCLOPRAMIDE HCL 128 128 57 120
LEVOFLOXACIN 128 127 57 83
WARFARIN SODIUM 124 124 59 16
FLUOXETINE HCL 114 108 60 63
LIPITOR 113 113 61 69
ALLOPURINOL 112 112 62 31
TRILIPIX 108 108 63 178
LANSOPRAZOLE 105 100 64 163
GEMFIBROZIL 103 102 65 96
MEGESTROL ACETATE 100 100 R 66 104
MECLIZINE HCL 99 98 67 122
ADVAIR DISKUS 94 94 68 45
PRAVASTATIN SODIUM 91 91 69 20
EXFORGE 90 90 70 155
NITROSTAT 89 89 71 193
ALCOHOL SWABS 88 88 72 319
NATEGLINIDE 88 88 72 220
CARBIDOPA-LEVODOPA 87 87 74 116
ACTONEL 87 87 74 92
POLYETHYLENE GLYCOL 3350 81 81 76 121
ACETAMINOPHEN-CODEINE 77 75 S3 77 80
MONOJECT INSULIN SYRINGE 76 76 78 527
CILOSTAZOL 76 76 78 202
CLONIDINE HCL 76 76 78 56
OXYBUTYNIN CHLORIDE ER 74 74 81 179
PANTOPRAZOLE SODIUM 73 69 82 29
DIOVAN HCT 72 72 83 64
FLUOCINONIDE 72 72 83 130
POTASSIUM CHLORIDE 71 71 85 28
ACTOS 70 70 86 71
FEXOFENADINE HCL 67 67 87 409
DIGOXIN 66 66 88 59
LISINOPRIL 61 61 89 3
HYDROCODONE-ACETAMINOPHEN 61 60 S3 89 5
ESCITALOPRAM OXALATE 60 60 91 86
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 92 97
EVISTA 56 56 93 90
RISPERIDONE 56 56 93 93
AZOR 56 54 93 152
PREMARIN 56 56 R 93 169
MUPIROCIN 55 54 97 294
FENOFIBRATE 55 55 97 74
HYDROCHLOROTHIAZIDE 52 50 99 9
ATELVIA 52 52 99 91
SERTRALINE HCL 52 51 99 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.